Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
30.48
-0.06 (-0.20%)
At close: Aug 1, 2025, 4:00 PM
30.50
+0.02 (0.07%)
After-hours: Aug 1, 2025, 4:10 PM EDT
Heartland Financial USA Revenue
Xenon Pharmaceuticals had revenue of $7.50M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $7.50M.
Revenue (ttm)
$7.50M
Revenue Growth
n/a
P/S Ratio
312.05
Revenue / Employee
$22,936
Employees
327
Market Cap
2.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 9.43M | -9.00M | -48.83% |
| Dec 31, 2021 | 18.44M | -13.73M | -42.68% |
| Dec 31, 2020 | 32.17M | 25.34M | 371.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
XENE News
- 1 day ago - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Xenon Joins the Russell 3000® and Russell 2000® Indexes - GlobeNewsWire
- 5 weeks ago - Xenon Announces Appointment of Darren Cline as Chief Commercial Officer - GlobeNewsWire
- 2 months ago - Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum - GlobeNewsWire
- 2 months ago - Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Xenon Pharmaceuticals Inc. (XENE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Xenon Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire